News
.png)
Dr. Paul Billings Joins Lindus Health's Scientific Advisory Board
Lindus Health has announced the appointment of Dr. Paul Billings to its Scientific Advisory Board, strengthening its expertise in diagnostic and genomic medicine. A recognized leader in diagnostics with decades of experience across industry and clinical research, Dr. Billings will help guide Lindus Health’s strategy for designing and executing high-quality diagnostic clinical trials, supporting faster, more reliable paths from diagnostic innovation to patient impact.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
%2520(1).jpeg)
Why I joined Lindus Health? Van Zyl Engelbrecht
The mission to accelerate clinical trial. The focus on making clinical research more patient-centric. The ability to support innovative health companies bring their product to market at a lower cost.
A Fireside Chat with ChatGPT
Despite this chat not taking place next to a real fire or being with a real person, we thought it worthwhile speaking to ChatGPT to ask: what does AI think about clinical trials?
The DTx Companies Disrupting the NHS
Check out the top 5 Dtx companies disrupting the NHS with their innovation, targeting sleep apnoea, cancer and anxiety!
.jpeg)
Lindusboards: Our Top 6 Immersive Therapeutics Companies
Welcome to LindusBoards! We have spent some time looking at some of the most cutting-edge Digital Therapeutics companies, and we couldn't not share them with you. First up, some of the coolest immersive therapeutics companies in the space right now. Think healthcare meets virtual reality... and then some!
.jpeg)
Product Clinic #7: It's a marathon, not a sprint
There is no better perspective of how our product team has grown and adapted as it has scaled than that of our first software engineer - Zaid! Our way of working is flexible and gives our engineers autonomy and the time to think meaningfully about what we need to build! Read our Product Clinic #7 to discover more about our engineering culture and how we balance speed and quality.
.jpeg)
Discussing DTx challenges and go-to-market in the UK with Charlotte Lee-Sinclair (ex-Big Health)
A fireside chat, this time by an actual fire! Our conversation with Dr Charlotte Lee-Sinclair is a must-read on DTx challenges and the road to go-to-market in the UK. Read here.
%2520(1).png)
Debunking the 3 biggest myths about decentralised trials
You've probably heard of decentralised clinical trials, but there are a lot of myths out there. Here we debunk the 3 biggest myths.
.jpeg)
Product Clinic #6: Releasing, Fast and Slow
Depending on your background, our 6 to 8 week product release cycle will evoke one of two reactions. If you work in the clinical space: Woah, what an incredibly fast release cycle! But if you work in a typical SaaS startup: How quaint, I release 3 times a day! Heard of Daniel Kahnemann's bestseller Thinking, Fast and Slow? Well, there is our inspiration!
.jpeg)
What taking intravenous ketamine taught me about clinical trial design
In the name of science, our co-founder, Meri Beckwith, took intravenous ketamine as part of a clinical trial. Find out what he has learnt about clinical trial design from his most recent trial experience.